Get the Stockscreener App
1.65
0.60%
-0.01
Iridex Corp stock is traded at $1.65, with a volume of 49,118.
It is down -0.60% in the last 24 hours and up +0.61% over the past month.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$1.66
Open:
$1.65
24h Volume:
49,118
Relative Volume:
1.34
Market Cap:
$27.45M
Revenue:
$48.43M
Net Income/Loss:
$-11.04M
P/E Ratio:
-2.4627
EPS:
-0.67
Net Cash Flow:
$-7.00M
1W Performance:
+2.29%
1M Performance:
+0.61%
6M Performance:
-17.09%
1Y Performance:
-40.65%
1-Day Range:
$1.63
$1.71
1-Week Range:
$1.62
$1.71
52-Week Range:
$1.2717
$3.65
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.65 | 27.45M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research - GlobeNewswire Inc.
Iridex reports steady Q4 sales, eyes profitability in 2025 - Investing.com
Iridex Reports Mixed Q4 Results: Revenue Up, Achieves Positive EBITDA Amid Strategic Review - StockTitan
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Stock Passes Below 200 Day Moving Average – Time to Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - Yahoo Finance
Iridex's MicroPulse Laser Therapy Shows Breakthrough Results in 5-Year Glaucoma Study - StockTitan
Medical Lasers Market Focused Insights 2024-2029: Mergers, - GlobeNewswire
Veterinary Eye Care Market to Grow by USD 1.05 Billion (2024-2028), Report on AI-Powered Market Evolution and Rising Pet OwnershipTechnavio - The Malaysian Reserve
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
IRIX Stock Surges Over 6% Amidst Medical Device Sector Decline - GuruFocus.com
Advancing Healthcare Tech: Medical Lasers Market Report 2024 - WhaTech
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - MSN
Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits | IRIX Stock News - StockTitan
IRIDEX Corp adjusts executive compensation, reshuffles board By Investing.com - Investing.com Australia
IRIDEX Corp adjusts executive compensation, reshuffles board - Investing.com India
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Yahoo Finance
Iridex: Q3 Earnings Snapshot - The Washington Post
Iridex Q3 Revenue Falls 10% YoY, Aims for Q4 EBITDA Breakeven Amid Strategic Review | IRIX Stock News - StockTitan
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
IRIX Stock Sees Significant Drop Amid Market Fluctuation - GuruFocus.com
IRIDEX Co. (NASDAQ:IRIX) Short Interest Up 9.9% in October - Defense World
Ophthalmic Photocoagulator Market to Witness Huge Growth by 2032 |Alcon, NIDEK, IRIDEX, Lumenis Be - openPR
IRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.com - Defense World
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseasesTechnavio - The Malaysian Reserve
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
IRIX stock touches 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa
IRIX stock touches 52-week low at $1.62 amid market challenges - Investing.com Australia
Iridex names Patrick Mercer as new CEO to drive strategic review - Investing.com
Iridex Appoints Patrick Mercer as Chief Executive Officer - StockTitan
Medical Laser Market Size, Share, Growth and Industry Trends – news - North America Agile Program ...
Medical Laser Technology Market Size, Share, Trends & Forecast - Third Eye News
Medical Lasers Market 2024: Exploring Industry Demand, Technological Advancements, And Future Prospects - WhaTech
Global Diabetes Associated Ophthalmic Treatment Market Size To Exceed USD 56.43 Billion By 2033 l CAGR Of 6.61% - India Shorts
Iridex (NASDAQ:IRIX) Stock Quotes, Forecast and News Summary - Benzinga
Laser Indirect Ophthalmoscope Market Report Analysis, - openPR
Iridex Frustrates, But Expect A Transaction By Year-End (NASDAQ:IRIX) - Seeking Alpha
Iridex finds accounting error, Q1 loss to widen by 1 cent/shr - Reuters
IRIDEX Corporation (NASDAQ:IRIX) Q2 2024 Earnings Call Transcript - Insider Monkey
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):